According to Renovaro Biosciences's latest financial reports the company's current earnings (TTM) are -NZ$87.17 M. In 2023 the company made an earning of -NZ$66.65 M an increase over its 2022 earnings that were of -NZ$0.18 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.